Erciyes BioGenome

Erciyes BioGenome Journal aim to publish that emphasize the molecular, cellular, and functional foundations within a broad range of scientific disciplines. These include: Molecular Biology and Genetics, Bioinformatics, Systems Biology, Neuroscience, Stem Cell Research, Biotechnology, Clinical Research, Metabolism and Chronic Diseases, Forensic Biology, Pharmacology. Basic and Clinical Medicine. Research in these fields can involve in plants, animals, cell lines, and humans, conducted under both in-vitro and in-vivo conditions. Additionally, we also accept meta-analysis studies.

Erciyes BioGenome Journal publishes relevant articles covering a broad spectrum of current topics in multidisciplinary fields. These fields range from research related to Molecular Biology and Genetics, Bioinformatics, Systems Biology, Neuroscience, and Stem Cells to Biotechnology, Clinical Research, Metabolism and Chronic Diseases, Forensic Biology, Clinical Medical Sciences, and drug research. We accept studies conducted in-vitro and in-vivo at the human, animal, plant, and cell levels, along with meta-analysis studies.

AUTHORSHIP

To qualify as an author, individuals must meet all four of the following criteria recommended by the Erciyes BioGenome:

-Every individual listed as an author must meet the authorship criteria recommended by the International Committee of Erciyes BioGenome (Erciyes BioGenome -www.erciyesbiogenome.org).

-Beyond being responsible for their own contributions, authors should have confidence in the integrity of their co-authors' contributions. Each author should also be able to identify which co-authors are responsible for specific parts of the work.

-Everyone designated as an author must meet all four of the defined authorship criteria above, and everyone who meets all four criteria should be identified as an author. It is the joint responsibility of the authors, not the journal to which the work is submitted, to ensure that those who do not meet all four criteria are not listed as authors.

-As part of the manuscript submission, the corresponding author must also provide a brief statement affirming their acceptance of full responsibility for authorship throughout the submission and review stages of the manuscript.

-The Editor is responsible for protecting intellectual property and defending the rights of both the journal and its author(s).

-Contributions that don't meet the authorship criteria should be listed in the "Acknowledgments" section.

-Conflicts of interest, financial support, grants, all other significant contributions (like statistical analysis or language editing), and/or technical assistance, if applicable, should be stated at the end of the text.

Substantial Contributions: They must have made significant contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of datas for the work.

Revision: They must have revised it critically for important intellectual content.

Final Approval: They must provide final approval of the version to be published.

Accountability: They must agree to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

-Authors must clearly state whether any financial and/or non-financial support was received during this study from any pharmaceutical company, medical device/equipment/material provider or manufacturer, or any commercial firm. This includes any support that could negatively influence decisions related to the study's evaluation process.

-Authors must clearly state whether there was any area of conflict of interest during the preparation of the study, including datas collection, interpretation of results, and manuscript writing stages.

-If the proposed publication relates to a commercial product, the author(s) must include a statement declaring that they have no financial or other interest in the product, or explain the nature of any relationship (including consultancies) between the author(s) and the product's manufacturer or distributor.

-The "Conflict of Interest Statement" found in the author forms must be signed by all authors.

-Erciyes BioGenome Journal requires a Copyright Agreement to be submitted with every manuscript. By signing this form, authors retain the copyright to their work. They also agree that if the article is accepted for publication by the Journal of Molecular Advances in Multidisciplinary Research, it will be licensed under a Creative Commons Attribution-NoDerivatives (CC BY-NC-ND) 4.0 International license.

-When using figures, tables, and similar content previously published in print or electronic format, the author(s) must obtain permission from the copyright holder. All legal, financial, and penal responsibilities regarding this matter rest solely with the author(s).

Correction and Retraction Requests

-Spelling errors in author names, affiliations, article titles, abstracts, keywords, and digital object identifiers (DOIs) can be corrected with an erratum.

Requests for retraction are also subject to Editorial Board approval.

-The statements or opinions expressed in articles published in the Erciyes BioGenome reflect those of the author(s), not necessarily those of the editors, editorial board, or publisher.

-The editors, editorial board, and publisher do not accept any responsibility or liability for such material.

-The ultimate responsibility for the published content lies with the authors.

Acknowledgments

-Contributions that don't meet the authorship criteria should be listed in the "Acknowledgments" section.

-Conflicts of interest, financial support, grants, all other significant contributions (like statistical analysis or language editing), and/or technical assistance, if applicable, should be stated at the end of the text.

Conflict of Interest

-Authors must clearly state whether any financial and/or non-financial support was received during this study from any pharmaceutical company, medical device/equipment/material provider or manufacturer, or any commercial firm. This includes any support that could negatively influence decisions related to the study's evaluation process.

-Authors must clearly state whether there was any area of conflict of interest during the preparation of the study, including datas collection, interpretation of results, and manuscript writing stages.

-If the proposed publication relates to a commercial product, the author(s) must include a statement declaring that they have no financial or other interest in the product, or explain the nature of any relationship (including consultancies) between the author(s) and the product's manufacturer or distributor.

-The "Conflict of Interest Statement" found in the author forms must be signed by all authors.

Copyright and Licensing

-Articles published by Erciyes BioGenome Journal are considered final versions. Therefore, after publication, correction requests are evaluated by the Editorial Board according to COPE guidelines.

Correction and Retraction Requests

-Articles published by Erciyes BioGenome Journal are considered final versions. Therefore, after publication, correction requests are evaluated by the Editorial Board according to COPE guidelines.

-Spelling errors in author names, affiliations, article titles, abstracts, keywords, and digital object identifiers (DOIs) can be corrected with an erratum.

Requests for retraction are also subject to Editorial Board approval.

Disclaimer

-The statements or opinions expressed in articles published in the Erciyes BioGenome reflect those of the author(s), not necessarily those of the editors, editorial board, or publisher.

-The editors, editorial board, and publisher do not accept any responsibility or liability for such material.

-The ultimate responsibility for the published content lies with the authors.

Manuscript Submission

-Submitting an article to Erciyes BioGenome Journal signifies that all authors have read and accepted the journal's publication policies and ethics.

-You can also track all processes related to your articles from this address.

- Manuscripts should be submitted by one of the authors of the manuscript. Submissions by anyone other than one of the authors will not be accepted.

INSTRUCTIONS FOR THE AUTHORS

MANUSCRIPT PREPARATION

Main Text

-Please submit your article as a Word document prepared with Times New Roman, 12-point font, and double-spaced. Do not submit your manuscript in PDF format.

Cover Letter

-A cover letter must be included with the submission, and it should state the corresponding author's complete contact information (affiliation, mailing address, email address, and phone number). Authors must also disclose if they have previously published or submitted any article related to the same work.

Title Page

-The title page should include the article's title, the full names and surnames of all authors, and the email, mailing addresses for all authors and affilations.

If the article has been previously presented as a communiqué (paper presented at a conference), the venue and date of the presentation must be stated.

Title

-Titles should be concise, specific, and informative. For scientific articles, avoid overly general titles, declarative titles, titles that reveal the direction of study results, or titles in the form of a question. For reports of clinical trials, meta-analyses, and systematic reviews, include the study type as a subtitle (e.g., Randomized Clinical Trial, Meta-analysis, Systematic Review, etc.).

Abstract

-The abstract should not contain references, figures, or table numbers. It must be between 250-300 words and cover the introduction, aim, materials and methods, findings, and discussion.

Keywords

-Keywords should be limited to 2-5 words and separated by semicolons (;). They must be listed in alphabetical order.

Abbreviations

-Any abbreviations used in the journal must be nationally or internationally accepted, defined in the text upon their first use, and placed in parentheses. Thereafter, the abbreviation should be used consistently throughout the text. For commonly accepted abbreviations and usage, please refer to "Scientific Style and Format" (https://www.scientificstyleandformat.org/Home.html).

Figures, Images, Tables, and Graphs

-The places where figures, images, tables, and graphs appear in the text must be indicated at the end of the relevant sentence and numbered.
- Figure legends, images, tables, and graphs must be added after the references in the manuscript.
-All abbreviations used must be stated in the legends below the figures, images, tables, and graphs.
-If previously published figures, images, tables, or graphs are used, written permission must be obtained, and this permission must be stated in the caption for the figure, image, table, or graph.
-Images/photos must be colorful, with sufficient contrast and clarity to show details.
-All information that could identify a person or institution in the visuals must be concealed.

Statistical Evaluation

-All retrospective, prospective, and experimental research articles must be biostatistically evaluated and presented with appropriate design, analysis, and reporting.

-The statistical tests used, along with the name and version of the statistical programs, must be clearly stated in the Materials and Methods section.

-Such explanations should include appropriate references to the original literature, especially for uncommon statistical tests and methods.

-Submitted articles are checked by the biostatistics editors if deemed necessary.

-Adherence to biostatistical rules in articles is the authors' responsibility.

Manuscript Category

Only original articles are published in Erciyes BioGenome Journal. 

Original Articles

Original articles must provide new information based on original research. The main text should be structured with the following subheadings:

-Introduction

-Materials and Methods

-Results

-Discussion

-Conflict of Interest

-Author Contributions

-Acknowledgments

-Ethical Approval (If ethical committee approval was obtained for the study, include the name of the relevant ethics committee and the ethics approval number.)

-Financial Support (If the study was supported by an institution, include the name of the supporting institution; if supported under a project, include the project support number.)

Abstract:

The abstract for research articles should be 250-300 words and include the Aim, Materials and Methods, Results and Discussion. It should be written in English and should not contain references.

Introduction:

The Introduction should cite relevant literature and clearly state the originality, scope, and aim of the study, supported by references.

Materials and Methods:

-Clearly and comprehensively describe all analyses, procedures, and experiments conducted in the study, supporting them with relevant references.

- List the names, brands, and catalog numbers of all consumables and fixed assets (e.g., microscopes, imaging systems) used during the study.

- If ethical committee approval was obtained for the study, include the name of the relevant ethics committee and the ethics approval number.

Compliance with Research Ethics Standards:

-All manuscripts involving human subjects must include a statement confirming that the study was approved by an institutional review board or a similar official research ethics review committee.

-If your institution lacks such a committee, you must provide a statement confirming the research was conducted in accordance with the principles of the Declaration of Helsinki (www.ma.net/e/policy/b3.htm). Additionally, there must be a statement indicating whether informed consent was obtained from the research subjects.

Results

-Present your results clearly, concisely, and without interpretation.

-Include statistical analysis results in this section to support your findings, where applicable.

Discussion

Explain your findings and relate them to the results of other authors. Then, describe their significance for clinical practice. The limitations, disadvantages, or shortcomings of the study should also be discussed in this section, preceding the concluding paragraph.

Decleration
The following declarations should be added to the end of the manuscript.
-Ethics Committee Approval : Ethics committee approval was received for this study from the XXX Ethics Committee of XXX University (Date: XXX, Number: XXXX)./This study does not require ethics committee approval.
-Informed Consent : Written and/or verbal consent was obtained from XXX participating in the study.
-Author Contributions : Concept-BK; Design-BK, AK; Supervision-BK, AK; Resources-BK, AK; Materails-BK, AK; Data Collection and/or Processing-BK, AK; Analysis and/or Interpretation- BK, AK; Literature Search- BK, AK; -Writing Manuscript- BK, AK; Critical Review- BK, AK.
-Declaration of Interests : The authors declare that there is no conflict of interest.
-Funding: This study was supported by XXX University Scientific Research Projects Department with project number XXXX/XX. / This research did not receive support from any funding agency/industry.
The study does not require ethics committee approval.

References

- The reference list, APA Style 7 must be used.

- References should be written using computer programs (such as Mendeley).

In Text Citations

-In text citations must be formatted using APA Style 7.

Revisions

When submitting a revised version of an article, authors must provide a "Response to Reviewers" document. This document should detail how each question from the reviewers was addressed, including where the changes can be found (each reviewer's comment, followed by the author's response and the line numbers where changes were made). Additionally, an annotated copy of the main document should be submitted.

Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the revised article is not submitted within the given timeframe, the revision option may be canceled. If the submitting author(s) believe they need additional time, they must request an extension before the initial 30-day period expires.

All spelling and grammar errors in submitted articles are corrected by our editorial committee without altering the presented datas.

PUBLICATION PROCESS

Accepted manuscripts will be made available and citable online as rapidly as possible. The stages of publication are as follows;

-Uncorrected publication: A PDF of the final, accepted (but unedited and uncorrected) paper will be published online on the journal web page under the “Accepted Articles” section. A DOI will be assigned to the article at this stage.

-Ahead-of-print publication: After copy editing, typesetting, and review of the resulting proof, the final corrected version will be added online in the “Ahead-of-Print” section.

-Final publication: The final corrected version will appear in an issue of the journal and added to the journal website. To ensure rapid publication, we ask authors to provide your publication approval during the proofreading process as quickly as possible, and return corrections within 48 hours of receiving the proof.

SUBMISSION CHECKLIST

Please use this list and the following explanations to prepare your manuscript and perform a final check before submission to ensure a timely review.

Formatting of text

• Text should be written in 12-point Times New Roman font

• Main headings and subheadings should be in 12-point and bold font

• Type a single space at the end of each sentence

• Do not use bold face for emphasis within the text

• Numbers one to ten are written out in words unless they are used as a unit of measurement, except in figures and tables

• Use a single hard return to separate paragraphs. Do not use tabs or indents to start a paragraph

• Do not use software options for hyphenation, headers, or footers

• Use page numbering

• Use US English

Ensure that the following items are present:

-Cover letter

-Title page including:

-Article type

-Article title

-Running title

-All author names and affiliations

-One author has been designated as the corresponding author with contact details

-Full postal address, phone number(s), and email address

-Acknowledge

-Manuscripts that have been presented orally or as a poster must include the name of the event, the date, and the location

-State financial or other support for the study

-Word count

-Abstract word count

-Text word count

Main text of the manuscript must include:

-Article title

-Abstract

-Keywords

-Text with required subheadings

- References (ensure written according to journal rules)

-Figures and tables

-Numbered according to text citation

-Descriptive legends/titles and abbreviations

-Ensure all figure and table citations in the text match the files provided

-Ensure that the following forms have been properly completed and submitted:

• General Principles for Reporting Statistical Methods and General Principles for Reporting Statistical Results

Further review

-Check the statistical analysis

-Use the US English spell check and grammar check software functions

-Check that all references cited in the text are correctly listed in the reference list

-Permission has been obtained for use of copyrighted material from other sources (including the Internet)

-All abbreviations have been identified

-All figures and tables are correctly labeled

-Journal policies detailed in this guide have been followed

ETHICS AND POLICIES

ETHICS

-The journal's editorial and publication processes are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and the National Information Standards Organization (NISO).

-The journal adheres to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).

-For studies conducted on humans or animals, or studies using their samples, approval from the relevant ethics committee and, if necessary, permission from the Ministry of Health must be obtained. Authors may be requested to provide ethics committee reports, approval documents, or equivalent official documentation. The manuscript must include the protocol number of the ethics committee approval and the name of the institution from which the ethics committee approval was obtained.

-If a study has been granted an exemption from ethical approval, this must also be stated in detail in the manuscript, including the name of the ethics committee that granted the exemption and the reason for the exemption. Further information and documentation should be submitted to the Editor to support this. Manuscripts may be rejected if the Editor believes the research was not conducted within an appropriate ethical framework. In rare cases, the Editor may contact the ethics committee for further information.

-If ethical approval was not obtained before the commencement of a study, retrospective ethical approval generally cannot be acquired, and the manuscript may not be eligible for peer review.

-Authors reporting the use of a new technique, new procedure, or a new tool/instrument/device must clearly explain within the article the rationale for why the new procedure or tool/instrument/device is considered more appropriate than existing conventional practices. Authors are required to have obtained ethics committee approval and informed patient consent for the experimental use of the new procedure or tool on human or animal subjects.

For human-related research:

-For manuscripts that include experimental research on human subjects or using human samples, a statement confirming that written, informed consent was obtained from patients and volunteers must be included.

-For all research involving human participants, informed consent for participation in the study must be obtained from the participants , from their parents or legal guardians in the case of children under 16 years of age or vulnerable groups where there's a potential for coercion (e.g., unconscious patients) and a statement to this effect must be included in the manuscript.Consent must be obtained for all types of personally identifiable data, including biomedical, clinical, and biometric data. If necessary, informed consent documents obtained from patients and volunteers may be requested.

-The statement regarding patient consent, the name of the ethics committee, the date of ethics committee approval, and the approval number must be specified in the Materials and Methods section of the manuscript.

-It is the authors' responsibility to protect patients' personal rights and consent documents.For photographs that could reveal patients' identities, signed permissions from the patient or their legal representative must be included.

-In articles describing transplantation studies, authors must include a statement declaring that organs/tissues were not obtained from prisoners and must also specify the institution(s)/clinic(s)/department(s) from which the organs/tissues were obtained. Documentary evidence of consent should be provided if requested.

-Manuscripts that include stem cells derived from various human tissues (excluding embryonic stem cells), their related biological products (e.g., exosomes), and all experimental and clinical applications involving them will be considered for evaluation. However, authors must confirm that the studies were conducted in accordance with relevant guidelines and regulations, and provide documentation if requested.

-Manuscripts must include an ethics statement that identifies the institutional and/or national research ethics committee (including the committee's name) that approved the experiments, and explains all relevant details. When necessary, authors must confirm that informed consent has been obtained from the recipients and/or donors from whom cells or tissues were acquired. Consent documents may be requested by the editor.

-Authors are required to follow the principles outlined in the 2016 International Society for Stem Cell Research (ISSCR) Guidelines for Stem Cell Research and Clinical Translation. The decision on whether to publish reviews concerning human germline modifications will be made by the editor, taking into account safety considerations and applicable regulations.

For animal-related research:

-For studies conducted on animals, the measures taken to prevent pain and suffering of the animals must be clearly stated. A statement regarding local ethics committee approval for animal studies, along with the name of the ethics committee, the approval date, and the protocol number, must be included in the Materials and Methods section of the manuscript.

-For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard of veterinary care.

-Field studies and other non-experimental research conducted on animals must comply with institutional, national, or international guidelines and be approved by an appropriate ethics committee or ministry/authorized body.

-A statement detailing compliance with the relevant guidelines and/or appropriate permits or licenses must be included in the manuscript. Authors are required to comply with the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).

-Manuscripts must include a statement specifying that appropriate permits and/or licenses were obtained for the collection of plant or seed specimens.

-Authors must comply with the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).

For Plant Research:

-Manuscripts must include a statement specifying that appropriate permits and/or licenses were obtained for the collection of plant or seed specimens.

-Authors must comply with the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).

-To support reproducibility, voucher specimens/labels for all wild plants described in the manuscript must be preserved. Information regarding the voucher specimen's label and by whom it was identified should be included in the manuscript.

-Experimental research and field studies on plants (cultivated or wild), including their collection, must comply with relevant institutional, national, and international guidelines and regulations.